Prevention trial for Contact Dermatitis
Official title Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and Silicone-Based Patches for Its Prevention in Children and Adolescents With Type 1 Diabetes
ClinicalTrials.gov ID: NCT07767461
What this study is testing
- What it's testing
- The study wants to find out how often skin irritation comes back after using different patches under insulin pumps or glucose monitors, and which patch works better.
- Who it's for
- Children and teens aged 2 to 18 who have skin irritation from a diabetes device.
- What's involved
- Participants will fill out questionnaires, have skin exams, photos taken, height/weight measured, a blood test for long‑term glucose control, a skin gene test, a skin ultrasound, tape stripping, and a harmless electrical skin test. They will visit the clinic three times.
- Time commitment
- The study lasts about a few weeks to months, with three clinic visits and several tests during each visit.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 18
You may be able to join if
- An type of contact dermatitis caused by an insulin pump or a continuous glucose monitor (CGM)
- Age between 2-18 years prior to inclusion
You likely can't join if
- Inability to read and understand Danish
- Cognitive impairment that may interfere with the ability to complete questionnaires in Danish or to participate in telephone or video follow-up visits
The study team makes the final eligibility decision.
Where it is enrolling
- Copenhagen, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Copenhagen, Denmark. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.